1. Pharmacia Corporation (22 from 200 patents)

2. G.d. Searle & Company (12 from 1,323 patents)

3. Pfizer Corporation (6 from 4,455 patents)

4. Astrazeneca Ab (1 from 1,500 patents)

5. Abbvie Inc. (1 from 822 patents)

6. Corridor Pharmaceuticals, Inc. (1 from 1 patent)

7. Pharmacia Corporation Global Patent Department (1 from 1 patent)

1. 9447122 - Arginase inhibitors and methods of use thereof

2. 8906911 - Chemokine receptor antagonists

3. 8894970 - Arginase inhibitors and methods of use thereof

4. 8044052 - Biaryl ether urea compounds

5. 7700658 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity

6. 7259266 - Benzopyran compounds useful for treating inflammatory conditions

7. 7253211 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity

8. 7122536 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity

9. 7119203 - Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors

10. 6951889 - 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors

11. 6890928 - Aromatic sulfone hydroxamic acids and their use as protease inhibitors

12. 6803388 - (R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

13. 6765023 - Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

14. 6723752 - (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

15. 6723753 - Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity